A growing body of preclinical research continues to explore its mechanisms and applications, including emerging work on neuroprotective effects and potential roles in spinal cord injury recovery
[5] Administering 100,000 IU intramuscularly establishes a high-capacity depot that may correct deficiency more predictably than oral dosing in malabsorption syndromes and maintains adequate circulating vitamin D over two to three months, an approach often referred to as Stoss therapy in endocrinology
This enzyme plays a role in regulating cellular energy metabolism, making 5-Amino-1MQ a focus of research into obesity, metabolic disorders, and age-related energy decline
Verdict: Limited evidence there are plausible gut-related mechanisms and some encouraging animal findings, but published human outcome data is too sparse and too poorly reported to confirm real clinical benefits [6][1113]
Rachele Pojednic, Chief Science Officer at Restore